Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915363 · ClinicalTrials.gov registry record · NA
BioPoly® Partial Resurfacing Knee Implant IDE
A NA study of Knee Osteoarthritis and Knee Pain Chronic, sponsored by BioPoly.
- Recruiting
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT06915363: Recruiting NA study of Knee Osteoarthritis and Knee Pain Chronic, sponsored by BioPoly.
NCT06915363 is a NA study of Knee Osteoarthritis and Knee Pain Chronic that is actively recruiting participants, run by BioPoly. The registered enrollment target is 152 participants, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06915363, a NA study of Knee Osteoarthritis and Knee Pain Chronic, is actively recruiting participants, sponsored by BioPoly.
- RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized controlled clinical trial is to demonstrate the safety and effectiveness of the BioPoly® Partial Resurfacing Knee Implant for the treatment of cartilage defects of the distal femur in adult patients with knee pain and symptoms who are candidates for surgical intervention of the knee compared to outcomes for the control group. The primary effectiveness endpoint is Month 24 composite clinical success (CCS) defined by: * no secondary surgical intervention (SSI) and * an improvement from baseline in the Knee injury and Osteoarthritis Outcome Score (KOOS) total score (scaled 0 to 100) of at least 10 points. Researchers will compare the CCS for the investigational device group to a control group receiving the standard of care, either microfracture or debridement). Subjects randomized to the investigational group will receive the BioPoly Knee device and those randomized to the control group will receive the current standard of care, either microfracture or debridement.
Primary Outcome
An improvement from baseline in the Knee injury and Osteoarthritis Outcome Score (KOOS) total score (scaled 0 to 100) of at least 10 points. If this criteria is met, the subject will be considered as a success relative to the measure of the Clinical Composite Success for effectiveness.
Conditions Studied
Interventions
- DEVICE BioPoly
- PROCEDURE surgical standard of care (SSOC)
Study Locations (1)
Indiana
- Dupont Hospital - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2025-03-17 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06915363 shows while recruiting
NCT06915363 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (50% lower).
The record links to 6 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which BioPoly is the first listed.
NCT06915363 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06915363 about?
NCT06915363 is a clinical study titled "BioPoly® Partial Resurfacing Knee Implant IDE". The goal of this randomized controlled clinical trial is to demonstrate the safety and effectiveness of the BioPoly® Partial Resurfacing Knee Implant for the treatment of cartilage defects of the distal femur in adult patients with knee pain and symptoms who are candidates for surgical intervention ...
What is the current status of trial NCT06915363?
This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2025-03-17. Estimated completion is 2028-12.
What conditions does trial NCT06915363 study?
This clinical trial studies the following conditions: Knee Osteoarthritis, Knee Pain Chronic, Cartilage Damage, Cartilage Defects of the Knee, Cartilage or Osteochondral Defects in the Knee.
What interventions are being tested in trial NCT06915363?
The interventions under investigation include: BioPoly (DEVICE), surgical standard of care (SSOC) (PROCEDURE).
Who is sponsoring clinical trial NCT06915363?
This trial is sponsored by BioPoly, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06915363 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06915363's enrollment target sits among peer trials
152 33rd of 101 higher than 69 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis
RECRUITING · NA
-
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
RECRUITING · NA
-
Mechanical Alignment Vs Kalipered Kinematic Alignment Total Knee Arthroplasty
RECRUITING · NA
-
Investigating Patient Satisfaction With Smart Knee Implants
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
-
Knee Biofeedback Rehabilitation Through Game Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI